The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPLZL.L Regulatory News (PLZL)

  • There is currently no data for PLZL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Noteholders’ consent solicitation extension

25 Aug 2022 16:05

RNS Number : 2749X
PJSC Polyus
25 August 2022
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Press Release 25 August 2022

 

Noteholders' consent solicitation extension

 

PJSC Polyus (LSE, MOEX: PLZL) («Polyus», or the «Company») highlights the announcement made by its indirect wholly-owned subsidiary Polyus Finance Plc («Issuer») earlier today on the extension of the consent solicitation process («Consent Solicitation») for its outstanding U.S.$700,000,000 3.25% Guaranteed Notes due 2028 («Notes»).

 

The terms of the earlier announced Consent Solicitation are detailed in the Consent Solicitation Memorandum dated 20 July 2022 ("Memorandum"). Capitalised terms used in this announcement but not defined herein have the meanings given to them in the Memorandum.

 

The Issuer announces and notifies the Noteholders of the Notes that it has decided to extend the Consent Deadline from 25 August 2022 (5:00 p.m. (London time)) to 8 September 2022 (5:00 p.m. (London time)).

 

No further actions are required from Noteholders of the Notes who have already delivered Consent Instructions in the Consent Solicitation.

 

All other terms of the Consent Solicitation will remain the same, unless further extended or earlier terminated by the Issuer.

 

New Expected Timetable

· Consent Deadline - 8 September 2022 (5:00 p.m. (London time))

The following table sets forth details of the Notes:

Description of the Notes

ISIN Code/

Common Code

(Regulation S Notes)

ISIN Code/

Common Code/

CUSIP Code

(Rule 144A Notes)

Outstanding Principal Amount

U.S.$700,000,000 3.25% Guaranteed Notes due 2028

XS2396900685

239690068

US73181LAB71 /

239725104 /

73181LAB7

U.S.$700,000,000

Copies of the Memorandum can be obtained by registering on the Consent Solicitation Website at https://i2capmark.com/event-details/59/Holder/polyus-finance-plc

Announcements in connection with the Consent Solicitation will be disclosed by the Issuer on the website of the London Stock Exchange. Copies of all announcements, notices and press releases are available on the Consent Solicitation Website https://i2capmark.com/event-details/59/Holder/polyus-finance-plc

Questions and requests for assistance in connection with the delivery of Consent Instruction may be directed to i2 Capital Markets (the Information and Tabulation Agent) at info@i2capmark.com and at +44 203 633 1212.

Questions and requests for assistance in connection with the Consent Solicitation may also be directed to the Investor Relations Department of PJSC Polyus at ir@polyus.com and at +7 495 641 33 77.

 

Polyus

Polyus is the world's fourth-largest gold mining company by production volumes and the largest gold miner in terms of attributable gold ore reserves. The Company has the lowest production costs among major global gold producers. Its principal operations are located in Siberia and the Russian Far East: Krasnoyarsk, Irkutsk and Magadan regions and the Republic of Sakha (Yakutia).

 

Investor and Media contact

Victor Drozdov,

Director Communications & Investor Relations (CIR) Department

+7 (495) 641 33 77

drozdovvi@polyus.com

Forward-looking statements

This announcement may contain "forward-looking statements" concerning Polyus and/or Polyus group. Generally, the words "will", "may", "should", "could", "would", "can", "continue", "opportunity", "believes", "expects", "intends", "anticipates", "estimates" or similar expressions identify forward-looking statements. The forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Forward-looking statements include statements relating to future capital expenditures and business and management strategies and the expansion and growth of Polyus' and/or Polyus group's operations. Many of these risks and uncertainties relate to factors that are beyond Polyus' and/or Polyus group's ability to control or estimate precisely and therefore undue reliance should not be placed on such statements which speak only as at the date of this announcement. Polyus and/or any Polyus group company assumes no obligation in respect of, and does not intend to update, these forward-looking statements, except as required pursuant to applicable law.

 

DISCLAIMER

This announcement must be read in conjunction with the Memorandum. This announcement and the Memorandum contain important information which should be read carefully before any decision is made with respect to the Consent Solicitation. If any Noteholder is in any doubt as to the action it should take or is unsure of the impact of its participation in the Consent Solicitation, it is recommended to seek its own financial advice, including in respect of any tax consequences, immediately from its stockbroker, bank manager, solicitor, accountant or other independent financial or legal adviser. Any individual or company whose Notes are held on its behalf by a broker, dealer, bank, custodian, trust company or other nominee must contact such entity if it wishes to participate in the Consent Solicitation.

None of the Issuer, the Guarantors, the Trustee, the Information and Tabulation Agent or any director, officer, employee, agent or affiliate of any such person, is acting for any Noteholder, or will be responsible to any Noteholder for providing any protections which would be afforded to its clients or for providing advice in relation to the Consent Solicitation, and accordingly none of the Issuer, the Guarantors, the Trustee, the Information and Tabulation Agent or their respective directors, officers, employees, affiliates, advisers or agents makes any recommendation as to whether Noteholders should provide Consent, or refrain from taking any action in the Consent Solicitation with respect to their Notes, and none of them has authorised any person to make such recommendation. The Information and Tabulation Agent is agent of the Issuer and owe no duty to any Noteholder.

This announcement is for informational purposes only. The Consents are only being solicited pursuant to the Memorandum and only in such jurisdictions as is permitted under applicable law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFSTEIEFIF
Date   Source Headline
23rd Sep 20202:53 pmRNSPolyus to consolidate 100% of SL Gold
22nd Sep 20202:35 pmRNSResults of exercise of pre-emptive right
22nd Sep 202012:33 pmRNSConsolidation of Lenzoloto assets
7th Sep 20207:53 amRNS1H 2020 Dividend Recommendation
7th Sep 20207:29 amRNSNotice of EGM - replacement
7th Sep 20207:00 amRNSFinancial results for the second quarter of 2020
1st Sep 20209:06 amRNSNotice of financial results 2Q2020
20th Aug 202011:20 amRNSNotice of EGM - Replacement
20th Aug 20209:19 amRNSNotice of EGM
20th Aug 20209:12 amRNSAppointment of Senior Independent Director
19th Aug 20201:44 pmRNSResult of AGM
17th Aug 20207:29 amRNSConsolidation of Lenzoloto assets
7th Aug 202010:54 amRNSThe commencement date of placement of the shares
7th Aug 20207:00 amRNSPre-emption right notice
6th Aug 20205:52 pmRNSDetermination of the issuance price
30th Jul 20205:48 pmRNSDirector/PDMR Shareholding
16th Jul 20207:00 amRNSTrading update for the second quarter of 2020
15th Jul 20203:52 pmRNS2H 2019 Dividend Recommendation and 2019 AGM
23rd Jun 20203:08 pmRNSEGM results
1st Jun 20207:00 amRNSFinancial results for the first quarter of 2020
28th May 20209:10 amRNSDirector/PDMR Shareholding
22nd May 20202:20 pmRNSNotice of financial results for 1Q2020
18th May 20204:05 pmRNSThe proposed placement of new ordinary shares
18th May 20203:44 pmRNSNotice of EGM
14th May 20203:07 pmRNSCompletion of the early redemption
14th May 20202:57 pmRNSCompletion of the early redemption
11th May 202012:01 pmRNSDirector/PDMR Shareholding
30th Apr 20206:30 pmRNSPolyus publishes its 2019 Annual Review
30th Apr 20201:15 pmRNSDirector/PDMR Shareholding
29th Apr 20204:14 pmRNSOre Reserves and Mineral Resources Update
29th Apr 20203:46 pmRNSDirector/PDMR Shareholding
23rd Apr 20207:00 amRNSTrading update for the first quarter of 2020
17th Apr 20205:29 pmRNSDirector/PDMR Shareholding
17th Apr 20205:02 pmRNSOptional redemption of 2021 convertible bonds
17th Apr 20204:45 pmRNSNotice to Bondholders: Optional Redemption Notice
30th Mar 20205:36 pmRNSCompany update on COVID-19 prevention procedures
26th Mar 20205:17 pmRNSDirector/PDMR Shareholding
26th Mar 20203:07 pmRNSEstablishment of a COVID-19 Fund
19th Feb 20204:38 pmRNSPolyus' MSCI ESG rating upgraded to A
11th Feb 20207:00 amRNSFinancial results for 4Q and FY2019
4th Feb 20207:00 amRNSNotice of financial results for 4Q and FY2019
28th Jan 20207:00 amRNSTrading update for 4Q and FY2019
24th Jan 20207:00 amRNSS&P Global Ratings revises Outlook on PJSC Polyus
31st Dec 20197:46 amRNSDirector/PDMR Shareholding
27th Dec 201911:23 amRNSResults of the share issuance
27th Dec 201911:12 amRNSResults of the closed subscription for shares
24th Dec 20191:01 pmRNSResults of exercise of pre-emption right
24th Dec 201911:08 amRNSDirector/PDMR Shareholding
6th Nov 20195:51 pmRNSNew shares issuance update
6th Nov 20194:24 pmRNSNotice of pre-emption right

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.